Harmony Biosciences Holdings, Inc. Free Cash Flow 2019–2025
Harmony Biosciences Holdings, Inc. reported $347.89M of free cash flow for fiscal 2025. That was 59.1% higher than fiscal 2024. Compared with fiscal 2020, the change was +11746.8%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $347.89M | +59.1% |
| FY 2024 | $218.67M | -0.2% |
| FY 2023 | $219.07M | +51.8% |
| FY 2022 | $144.29M | +46.9% |
| FY 2021 | $98.26M | +3389.6% |
| FY 2020 | $-2.99M | +96.0% |
| FY 2019 | $-75.58M | — |
Source: Harmony Biosciences Holdings, Inc. SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open HRMY 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Harmony Biosciences Holdings, Inc. reported $347.89M of free cash flow for fiscal 2025. That was 59.1% higher than fiscal 2024. Compared with fiscal 2020, the change was +11746.8%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Harmony Biosciences Holdings, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHarmony Biosciences Holdings, Inc. — frequently asked questions
What is Harmony Biosciences Holdings, Inc.'s free cash flow?
Harmony Biosciences Holdings, Inc. (HRMY) reported free cash flow of $347.89M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Harmony Biosciences Holdings, Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.